Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Martek Biosciences---- future biotech cash cow! -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (122)	1/7/1998 8:28:00 PM
From: Machaon	Read Replies (1) \| Respond to of 258

Richard, so far as I can find, Monsanto's DHA is from Algae, as you said, and their first commercial product was Omega-3 DHA eggs, which was marketed overseas starting in 1996. So...... they've been at the Algae-DHA game for a while. I couldn't find anything about them getting into "full term" infant formula (It doesn't mean that they aren't planning to do this), and I'm not thru looking. I, also, don't like the idea of a Monsanto Giant "possibly" competing against tiny Martek. But, I like the fact that three execs from Merck thought highly enough about Martek to switch companies. They must know something that we don't, right? In other words, why leave the comfort of Merck's executive washrooms for Martek's keyless one-room bathrooms, if there aren't significant "other" benefits, or a significant opportunity for success?! I'm going to keep looking for some Monsanto DHA stuff. Do you remember if the article mentioned anything about formula? It really makes sense for them to get into this area. It looks like it could be very profitable. I'm going to look for patent info also. Perhaps someone with more knowledge than myself can call the company on this matter? Thanks, Bob